1,4-β-D-N-Acetylglucosaminyl-D-glucosamine
1,4-β-D-N-Acetylglucosaminyl-D-glucosamine (Compound 3) is a DA-pNP derivative. 1,4-β-D-N-Acetylglucosaminyl-D-glucosamine can be used in the research of systemic sclerosis[1].
Product Specifications
CAS Number
245733-17-9
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
OC[C@@H](O[C@H]([C@@H]([C@H]1O)NC(C)=O)O)[C@H]1O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2N)O)O)CO
Molecular Formula
C14H26N2O10
Molecular Weight
382.36
References & Citations
[1]Harmsen RAG, et al. Chemoenzymatic Synthesis of Chito-oligosaccharides with Alternating N-d-Acetylglucosamine and d-Glucosamine. Biochemistry. 2020 Dec 8;59 (48) :4581-4590.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880253-100 1x 100 µL
Cytokeratin, LMW (AE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880008-100 1x 100 µL
MAGE A1 (MA454), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 